Recent Updates
Recently added Catalysts
SKIN Positive Sentiment

Document BeautyHealth Appoints Philippe Schaison, PharmaD, to Board of Directors Global Aesthetics Leader Brings Deep Industry Expertise and Proven Track Record Driving Growth Across Health, Beauty, and Consumer Sectors

Key Takeaway: The BeautyHealth Company (NASDAQ SKIN) appointed Philippe Schaison, PharmaD, to its Board of Directors, effective October 30, 2025. Schaison brings over 20 years of experience in the aesthetics, biotech, and consumer health sectors, and has held leadership positions at notable companies such as Allergan and Johnson & Johnson. This appointment is expected to enhance the company's growth strategy, particularly for its flagship brand, Hydrafacial. Additionally, Schaison will contribute to the Board's Compensation and Nominating Corporate Governance Committees.
Price reaction · baseline $1.43 (2025-10-31 close) · 1 other SKIN headline(s) in the window, move may be shared
day 0 close · peak
-4.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Appointment of Philippe Schaison is expected to drive growth and innovation.
  • Dr. Schaison has extensive experience in global aesthetics and biotechnology.
  • His leadership could enhance the potential of the Hydrafacial brand.

Full Press Release Details

BeautyHealth Appoints Philippe Schaison, PharmaD, to Board of Directors
Global Aesthetics Leader Brings Deep Industry Expertise and Proven Track Record Driving Growth Across Health, Beauty, and Consumer Sectors
LONG BEACH, Calif.--(BUSINESS WIRE)-November 3, 2025 - The BeautyHealth Company (NASDAQ SKIN), home to flagship brand Hydrafacial, today announced the appointment of global aesthetics leader, Philippe Schaison, PharmaD, to its Board of Directors, effective as of October 30, 2025.
Dr. Schaison has spent over 20 years leading organizations across the global aesthetics, biotech, and consumer health industries. He currently serves as Chief Executive Officer and a director of Solt go, Inc., a bio-cosmetic company. Previously, Dr. Schaison was Chief Executive Officer NA of Syneron Candela, President of Allergan Aesthetics, and held senior leadership roles at Clarins, Johnson Johnson, and L'Or al. Today, Dr. Schaison serves as Chairman of the Board of Raziel Therapeutics Ltd., an Israeli-based biotechnology company, and sits on a number of other biomedical company boards including AIVITA Biomedical, Inc., Dyve Biosciences, Inc., and miraDry, Inc. Dr. Schaison earned an M.B.A. from Hautes Etudes Commerciales in Paris, and a Doctorate in Pharmacy from the Universit Paris V Ren Descartes.
BeautyHealth Executive Chairman Brent Saunders said "Philippe's experience scaling global beauty and aesthetics businesses, coupled with his proven ability to drive innovation and profitability, will bring invaluable perspective to the BeautyHealth Board. His deep expertise will help the Company unlock the full potential of the dynamic Hydrafacial brand, elevate our global reach, and accelerate category growth."
Dr. Schaison fills an open seat on the BeautyHealth Board and will join the Compensation and Nominating Corporate Governance Committees. Following the appointment, BeautyHealth's Board will be comprised of eight directors.
About The Beauty Health Company
The Beauty Health Company (NASDAQ SKIN) is a medtech meets beauty company delivering millions of skin health experiences every year that help consumers reinvent their relationship with their skin, bodies, and self-confidence. Our brands are pioneers Hydrafacial in hydradermabrasion, SkinStylus in microneedling, and Keravive in scalp health. Together, with our powerful global community of estheticians, partners, and consumers, we are personalizing skin health for all ages, genders, skin tones, and skin types. We are committed to being ever more mindful in how we conduct our business to positively impact our communities and the planet. Find a local provider at https hydrafacial.com find-a-provider and learn more at beautyhealth.com or LinkedIn.
Investors IR beautyhealth.com
Media press beautyhealth.com

Frequently Asked Questions

Who has been appointed to the BeautyHealth Board?

Philippe Schaison, PharmaD, has joined the BeautyHealth Board as of October 30, 2025.

What positions did Philippe Schaison hold before joining BeautyHealth?

He was CEO of Syneron Candela and President of Allergan Aesthetics, among others.

How many directors are on the BeautyHealth Board after this appointment?

The BeautyHealth Board now comprises eight directors following Dr. Schaison's appointment.

What roles will Dr. Schaison serve on the BeautyHealth Board?

He will join the Compensation and Nominating Corporate Governance Committees.

What is the flagship brand of The Beauty Health Company?

The flagship brand is Hydrafacial, specializing in skin health experiences.

Last updated: Nov 3, 2025